Join Growin Stock Community!

善德生技4115.TW Overview

TW StockBiotech. & Medical
(No presentation for 4115)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

善德生技（4115）Overall Performance

善德生技（4115）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

善德生技（4115） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

善德生技（4115）Key Information

善德生技（4115）Profile

Sunder Biomedical Tech. Co., Ltd. manufactures and sells medical devices. It offers protective goggles, melt blown nonwoven fabric and mask, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. Fistula needle set, I.V. administration, extension tube, volume control I.V. administration set, surgical tubing set, components, and transducer protector, as well as PVC compounds for medical applications. The company was founded in 1998 and is based in Taichung, Taiwan.

善德生技（4115）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.72
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.28
PB Ratio
0.58
Price-to-FCF
3.44
METRIC
VALUE
vs. INDUSTRY
Gross Margin
12.37%
Net Margin
-2.83%
Revenue Growth (YoY)
-30.24%
Profit Growth (YoY)
-44.55%
3-Year Revenue Growth
-3.52%
3-Year Profit Growth
-12.80%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.72
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.28
PB Ratio
0.58
Price-to-FCF
3.44
Gross Margin
12.37%
Net Margin
-2.83%
Revenue Growth (YoY)
-30.24%
Profit Growth (YoY)
-44.55%
3-Year Revenue Growth
-3.52%
3-Year Profit Growth
-12.80%
default symbol

4115

善德生技

7.05D

-6.38%

(-0.06)

  • When is 4115's latest earnings report released?

    The most recent financial report for 善德生技 (4115) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4115's short-term business performance and financial health. For the latest updates on 4115's earnings releases, visit this page regularly.

  • How much cash does 4115 have?

    At the end of the period, 善德生技 (4115) held Total Cash and Cash Equivalents of 97.94M, accounting for 0.08 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4115 go with three margins increasing?

    In the latest report, 善德生技 (4115) did not achieve the “three margins increasing” benchmark, with a gross margin of 10.99%%, operating margin of -4.88%%, and net margin of -5.13%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4115's profit trajectory and future growth potential.